Board approves enabling resolution for raising up to Rs 600 Crores

Fund Raising View source PDF Explain this filing

ORCHPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.7%Reaction day

₹891.00

prior close

₹885.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.6%+0.9% vs market

Pharmaceuticals peers, median of 172sector-1.7%-0.1% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+1.5

15m

+1.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.7-2.6+0.9-1.7-0.1

Next day

-1.6-3.6+2.0-2.2+0.6

-8.2-5.8-2.3-3.4-4.8

-8.4-5.5-2.9-2.3-6.1

-5.8-3.8-2.0-1.1-4.7

-3.4pendingpending+0.2-3.5

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Orchid Pharma's board approved an enabling resolution to explore raising funds up to Rs 600 Crores through equity shares, convertibles, QIP, private placement, public issue, or preferential issue. No specific mode, pricing, or use of funds decided yet. Requires shareholder and regulatory approvals.

Likely market impact

Potential equity dilution ahead as company explores fund raising of up to Rs 600 Crores, though structure is not finalised.